-------如果这里没有任何信息，不是真没有，是我们懒！请复制书名上amazon搜索书籍信息。-------
Exam Builder, Release Date April 1, 2021, Termination Date March 31, 2024INSTRUCTIONS:Download all compressed (.rar) files and put them into the same folder on your computer.Using WinRAR, extract the file part1.rar. This will automatically extract all other parts together.After extraction, run the file Exam Builder.html. This will start the lecture.BOARD-STYLE PRACTICE QUESTIONSCOMPREHENSIVE QUESTION BANK: 800+ Medical Oncology multiple-choice questions (MCQs) are included. Each question carefully follows the ABIM board exam content outline and format.REALISTIC TEST ENVIRONMENT: Prepare by taking practice tests in a format that’s just like the actual exam.THE “QBL” METHOD: “Question-Based Learning” ensures that your review is 100% relevant to the ABIM Medical Oncology exam. This proven method works by embedding multiple-choice questions into course lectures.OPTIMIZED FOR LEARNING: Unlike other Q Banks, The Pass Machine Medical Oncology practice questions include referenced explanations, so you learn the “how” and “why” behind every question.Intended Audience: OncologistsLearning Objectives:Upon completion of this program, participants should be able to:Assess diagnosis, staging and prognostic factors of breast cancer.Explain the different types of gynecologic cancer.Describe basic pharmacological and biological principles in the management and treatment of cancer.Develop comprehensive management and treatment plans for genitourinary cancer including bladder, other urothelial, prostate, and renal cancer, and germ cell tumors.Demonstrate medical management of lung and thymic cancer and mesothelioma.Integrate modalities of care and ethics including treatment-related issues, complications, supportive care, survivorship, psychosocial aspects of cancer, bioethical/legal/economic issues, and communication skills.Content :Hematologic NeoplasmsAcute Leukemia and Myelodysplasia (1 Hour)Peter Silberstein, MDChronic Myeloid Leukemia and Myeloproliferative Neoplasms (1 Hour)Peter Silberstein, MDChronic Lymphoproliferative Leukemias (0.5 Hours)Peter Silberstein, MDMultiple Myeloma and Plasma Cell Dyscrasias (1 Hour)Peter Silberstein, MDNon-Hodgkin Lymphoma (1.5 Hours)Peter Silberstein, MDThoracic CancerNon-small Cell Lung Cancer (0.5 Hours)Christine M. Bestvina, MDSmall Cell Lung Cancer and Mesothelioma and Thymus Cancer (0.25 Hour)Christine M. Bestvina, MDBreast CancerPremalignant Conditions, High-risk Factors & Carcinoma in Situ (0.5 Hours)Skikha Jain, MDEarly-Stage Invasive Carcinoma (0.75 Hours)Jacob Thomas, MDLess Common Histologies and Clinical Scenarios (0.25 Hours)Jacob Thomas, MDLocally Advanced and Inflammatory Disease and Locally Recurrent Disease (0.25 Hours)Jacob Thomas, MDMetastatic Disease (1 Hour)Jacob Thomas, MDGenitourinary CancerGerm Cell Tumors (0.25 Hours)Skikha Jain, MDProstate Cancer (0.75 Hours)Skikha Jain, MDRenal Cell Cancer (0.5 Hours)Skikha Jain, MDUrothelial and other Genitorourinary Cancers (1 Hour)Skikha Jain, MDGynecologic CancerCancer of the Cervix, Vulva, & Vagina & Other Gynecologic Malignancies (0.5 Hours)Peter Silberstein, MDOvarian Cancer (1 Hour)Peter Silberstein, MDGastrointestinal CancerGastrointestinal: Pancreatic & Anal Cancer (1 Hour)Efrat Dotan, MDGastrointestinal: Biliary/Gallbladder Cancer & Neuroendocrine Tumors (0.75 Hours)Efrat Dotan, MDGastrointestinal: Colorectal Cancer (1.5 Hours)Efrat Dotan, MDGastrointestinal: Gastric Cancer (1 Hour)Efrat Dotan, MDGastrointestinal: Esophageal Cancer (0.75 Hours)Efrat Dotan, MDGastrointestinal: Hepatocellular Carcinoma (0.5 Hours)Efrat Dotan, MDSkin Cancer, Sarcomas, and Unknown Primary SiteBone and Soft Tissue Sarcomas and Unknown Primary Site Part I (0.5 Hours)Peter Silberstein, MDUnknown Primary Site Part II (0.5 Hours)Peter Silberstein, MDMelanoma and Other Skin Cancers (0.75 Hours)Jacob Thomas, MDAnticancer Therapeutics, Clinical Research Methodology, and EthicsAnticancer Therapeutics (2.25 Hours)Jacob Thomas, MDClinical Research Methodology and Ethics (0.5 Hours)Jacob Thomas, MDPrinciples of Allied Disciplines (0.75 Hours)Jacob Thomas, MDPalliative Care, Survivorship, and CommunicationCancer Pain I (0.5 Hours)Jacob Thomas, MDCancer Pain II and Survivorship Issues (0.5 Hours)Jacob Thomas, MDClinical Manifestations of Advanced Cancer and Its Treatment (1.5 Hours)Peter Silberstein, MDEnd-of-Life Issues (0.5 Hours)Peter Silberstein, MDProcedure-related Issues and Communication (0.5 Hours)Peter Silberstein, MDHead, Neck, Thyroid, and Central Nervous System MalignanciesHead & Neck Cancer (1.5 Hours)Ari Rosenberg, MDThyroid and Salivary Gland Cancer (0.5 Hours)Ari Rosenberg, MDCentral Nervous System Malignancies (0.5 Hours)Ari Rosenberg, MDGenetics and Tumor BiologyCancer Biology, Genetics, and Tumor Immunology (0.75 Hours)Akash Patnaik, MDHeritable Cancer Syndromes and Cancer Epidemiology (0.5 Hours)Akash Patnaik, MD
